Search Results - Kersch, Cymon
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Interactions between αv-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain by Lal, Sangeet, Kersch, Cymon, Beeson, Kathleen A., Wu, Y. Jeffrey, Muldoon, Leslie L., Neuwelt, Edward A.
Published 2015Text -
9
Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease by Ambady, Prakash, Fu, Rongwei, Netto, Joao Prola, Kersch, Cymon, Firkins, Jenny, Doolittle, Nancy D., Neuwelt, Edward A.
Published 2017Text -
10
Radiation enhances the delivery of antisense oligonucleotides and improves chemo-radiation efficacy in brain tumor xenografts by Ambady, Prakash, Wu, Yingjen Jeffrey, Kersch, Cymon N., Walker, Joshua M., Holland, Samantha, Muldoon, Leslie L., Neuwelt, Edward A.
Published 2021Text -
11
PATH-63. TRANSCRIPTIONAL SIGNATURES IN HISTOLOGIC STRUCTURES WITHIN GLIOBLASTOMA TUMORS MAY PREDICT PERSONALIZED TREATMENT SENSITIVITY AND SURVIVAL by Kersch, Cymon, Claunch, Cheryl, Ambady, Prakash, Bucher, Elmar, Schwartz, Daniel, Barajas, Ramon, Iliff, Jeffrey, Heiser, Laura, Muldoon, Leslie, Neuwelt, Edward
Published 2019Text -
12
Blood–brain barrier opening by intracarotid artery hyperosmolar mannitol induces sterile inflammatory and innate immune responses by Burks, Scott R., Kersch, Cymon N., Witko, Jaclyn A., Pagel, Michael A., Sundby, Maggie, Muldoon, Leslie L., Neuwelt, Edward A., Frank, Joseph A.
Published 2021Text -
13
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival by Kersch, Cymon N, Claunch, Cheryl J, Ambady, Prakash, Bucher, Elmar, Schwartz, Daniel L, Barajas, Ramon F, Iliff, Jeffrey J, Risom, Tyler, Heiser, Laura, Muldoon, Leslie L, Korkola, James E, Gray, Joe W, Neuwelt, Edward A
Published 2020Text -
14
Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors by Uluc, Kutluay, Ambady, Prakash, McIntyre, Matthew K, Tabb, John Philip, Kersch, Cymon N, Nerison, Caleb S, Huddleston, Amy, Liu, Jesse J, Dogan, Aclan, Priest, Ryan A, Fu, Rongwei, Prola Netto, Joao, Siler, Dominic A, Muldoon, Leslie L, Gahramanov, Seymur, Neuwelt, Edward A
Published 2022Text